Beyond Blast Counts: How Menin Inhibition Redefines AML Immunophenotypes and Survival
Posted inHematology-Oncology news Pathology & Lab Medicine/Bệnh học

Beyond Blast Counts: How Menin Inhibition Redefines AML Immunophenotypes and Survival

This study explores how the menin inhibitor revumenib induces significant immunophenotypic shifts in AML patients. Results show that over 50% of patients undergo lineage changes, and achieving MRD negativity remains the strongest predictor of long-term survival, necessitating new approaches to flow cytometry monitoring.
Peritoneal Cancer Risk After Risk-Reducing Salpingo-Oophorectomy: The Impact of BRCA Mutational Status and STIC Lesions
Posted innews OB/GYN & Women’s Health Oncology

Peritoneal Cancer Risk After Risk-Reducing Salpingo-Oophorectomy: The Impact of BRCA Mutational Status and STIC Lesions

This study of 1,351 high-risk women demonstrates that while risk-reducing salpingo-oophorectomy (RRSO) is effective, the presence of serous tubal intraepithelial carcinoma (STIC) at the time of surgery significantly increases the 5-year risk **Organizing the Information Now** I'm now drafting the content structure, meticulously extracting key data points from the abstract to populate the Patient Information, Diagnosis, and Treatment and Management sections. I'm taking special care with the crucial incidence rates (0.4% vs 11.1%) and the implications of STIC diagnosis, ensuring a clear and concise presentation within the JSON format. of peritoneal cancer to 11.1%.